Drug Trial Radar · NCT07699380
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
Last checked: Nov 19, 2026Latest source record: Sep 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Sep 2026
Primary completion
Dec 2029
Study completion Dec 2029
Sponsor
- Lead sponsor
- University of WashingtonAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Breakthrough T1D
- First posted
- Jul 13, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 69 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is a randomized, double-blind, parallel-group clinical trial to examine the effects of 24 weeks of oral AMX0035 (sodium phenylbutyrate + taurursodiol) versus placebo in 60 adults with Type 1 Diabetes (T1D) (n=30 per arm). Enrollment will be distributed equally between the University of Washington and Amsterdam University Medical Center/Diabetes Center Amsterdam. Participants will be recruited through diabetes research registries, local T1D clinics, and community outreach.
Conditions
- Type 1 Diabetes (T1D)
- Metabolic Diseases
- Glucose Metabolism Disorders
- Endocrine System Diseases
- Autoimmune Diseases
- Immune System Diseases
- Diabetes Melletus, Type 1
- Nutritional and Metabolic Diseases
- Combination Therapy
Interventions
AMX0035Drug
AMX0035 sachets
PlaceboDrug
Placebo sachets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in whole-body insulin sensitivity (M-value) measured by hyperinsulinemic-euglycemic clampTime frame: Baseline, 24 weeks
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
University of Washington Medicine Diabetes Institute (UWMDI)
Seattle, Washington · Recruiting
Amsterdam UMC
Amsterdam, Netherlands · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.